3937 Connexin 26
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous metal compounds | 2 | 6.3 | 0.32× | q = 0.04 | |
| Hydrocarbons | 2 | 0.1 | 22× | not tested | |
| Lipids and lipid-like molecules | 12 | 1.4 | 8.41× | not tested | |
| Benzenoids | 1 | 0.9 | 1.07× | not tested | |
| Organic oxygen compounds | 1 | 2.6 | 0.39× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB04327 | PEE | Phosphatidylethanolamine | 68 |
| DB04540 | CLR | Cholesterol | 57 |
| DB00141 | NAG | N-Acetylglucosamine | 14 |
| DB02329 | CBO | Carbenoxolone | 14 |
| DB02043 | LHG | 1,2-Dipalmitoyl-Phosphatidyl-Glycerole | 12 |
| DB00144 | P5S | Phosphatidyl serine | 6 |
| DB01136 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MC3 | 1,2-DIMYRISTOYL-RAC-GLYCERO-3-PHOSPHOCHOLINE | 408 |
| PTY | PHOSPHATIDYLETHANOLAMINE | 272 |
| CLR | CHOLESTEROL | 168 |
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 119 |
| Y01 | CHOLESTEROL HEMISUCCINATE | 85 |
| PEE | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine | 67 |
| C14 | TETRADECANE | 62 |
| POV | (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate | 42 |
| DGA | DIACYL GLYCEROL | 35 |
| YMZ | (11R,12S)- Mefloquine | 24 |
| LBN | 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine | 21 |
| ACD | ARACHIDONIC ACID | 12 |
| HE2 | HEXAN-1-OL | 12 |
| L9Y | 4-{[(2S)-2-butyl-6,7-dichloro-2-cyclopentyl-1-oxo-2,3-dihydro-1H-inden-5-yl]oxy}butanoic acid | 12 |
| LHG | 1,2-DIPALMITOYL-PHOSPHATIDYL-GLYCEROLE | 12 |
| QDN | Quinidine | 12 |
| QI9 | Quinine | 12 |
| YNJ | 7-{[(2S)-2-butyl-6,7-dichloro-2-cyclopentyl-1-oxo-2,3-dihydro-1H-inden-5-yl]oxy}heptanoic acid | 11 |
| CAmetal | CALCIUM ION | 8 |
| 6OU | [(2~{R})-1-[2-azanylethoxy(oxidanyl)phosphoryl]oxy-3-hexadecanoyloxy-propan-2-yl] (~{Z})-octadec-9-enoate | 7 |